Reprint

Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation

Edited by
November 2023
204 pages
  • ISBN978-3-0365-9233-6 (Hardback)
  • ISBN978-3-0365-9232-9 (PDF)

This book is a reprint of the Special Issue Efficacy, Safety, and Immunogenicity of Vaccines against Viruses: From Network Medicine to Clinical Experimentation that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary

This reprint emerges as a beacon guiding researchers, scientists, and medical professionals through uncharted territories. In this volume, we delve deep into the intricate world of immunization, where the fusion of bioinformatics and network medicine reshapes our understanding of vaccines' efficacy, safety, and immunogenicity.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
monkeypox; mpox; MPXV; universal vaccine; multi-epitope mRNA vaccine; immunoinformatics; influenza; H3N2; antigenic distance; hemagglutinin; attribute network embedding; herpes simplex virus; HSV-2; vaccine; costimulation; genital; antibodies; T cells; MDV; chickens; Th17 cells; IL-17A; interferon-gamma and adaptive immunity; adenoviral vector; cell fusion; human endogenous retrovirus type W (HERV-W); R-peptide; Syncytin-1; HIV; PLWH; ART; vaccination; immune responses; CD4; COVID-19; HPV; influenza; respiratory syncytial virus; RSV; mucosal vaccine; inactivated vaccine; low-energy electron irradiation; LEEI; PC formulation; PCLS; binding antibody assay; immune correlates of protection; modified treatment policy; neutralizing antibody assay; principal stratification; principal surrogate; SARS-CoV-2; stochastic intervention; stochastic interventional vaccine efficacy; peste des petits ruminants; ewes; lambs; vaccination; passive immunity; quadrivalent adjuvanted influenza vaccines; toll-like receptors; influenza; CVID; azoximer bromide